Healthcare - Informa AU’s Post

🚀 Exciting news! Biocat and Fenin have joined forces to accelerate innovation in the medical technology sector. This strategic alliance aims to enhance skills, promote emerging technologies, and drive impactful advancements in healthcare. 🌟 #Biocat #HealthcareLeadership #Innovation #MedTech #MedicalTech #Partnership #RegulatoryAgencies #MarketAccessToday #MarketAccess

🌟 This morning’s roundtable discussion on the skill gaps in the European Biotech Industry was a fountain of insights! Thank you for your contribution Paul Bravetti, Jan Van den Bossche , Luis Pareras MD, PhD , beatriz llamusi , Edward Van Wezel 👏👏👏👏 These conversations underscore the necessity of #collaborative efforts to shape a thriving future for Biotech industry and something that WorkInHealth Foundation created by EIT Health Aims to navigate through our skills observatory. One critical insight from today’s discussion centered on the challenge of sourcing top-tier talent. As biotech sector grows, so does the demand for skilled professionals who are not only proficient in their scientific disciplines but also agile in adapting to the fast-evolving landscape of biotech, like AI. 🤝 Looking forward to continuing these conversations and meeting many of you in person at the @HealthTech conference. Together, we are setting the stage for transformative impacts in biotechnology! #innovation #leadership #skillsgap #talentgap

See Trajan in the latest Stockhead Health and Biotech Investor Guide.

🌟 Elevating Patient Voices in Biotech 🌟 We're diving deep into the transformative power of patient-centricity in biotechnology. Our latest blog explores how this essential approach is reshaping the development and delivery of treatments, leading to more effective and personalized healthcare solutions. Dive into the details and discover how we embrace these changes to innovate and improve patient outcomes. #Biotech #PatientCentricity #HealthcareInnovation https://lnkd.in/gTR7dwjN

At HiRO, we understand the hurdles biotech companies face from conception to market. Our tailored CRO services support these pioneers in transforming healthcare through innovation. Dive into how we're reshaping the journey for biotech innovations and providing the tools needed for success. Learn how HiRO is driving biotech breakthroughs: https://lnkd.in/gkhsnk-3 #BiotechInnovation #ClinicalResearch #HiRO

At SR One, we work to power the #innovation arc from disruptive technology to differentiated medicine. We believe that a back and build approach, which aims to pair great science with great people, has the potential to propel impactful companies through every inflection point. Discover our #portfoliocompanies who are making disruptions: https://lnkd.in/gmgM5Chu #BioPharma #Investing #VentureCapital

In the world of biotech, resource constraints and experience can hinder innovation. HiRO steps in as a vital partner, providing biotech companies with the team of professionals they need, from project managers to statisticians, ensuring every innovative concept has the chance to become a life-changing treatment. Dive into our blog to understand how HiRO supports biotech: https://lnkd.in/gNk-SpPa #BiotechDevelopment #ClinicalTrialExperts #InnovativeResearch #HiROSupport #HealthcareProgress

The landscape of #Biopharma #Research is undergoing a profound transformation, and it's a moment we can't afford to overlook. For far too long, the industry has grappled with challenges like low productivity, high failure rates, and interminable development timelines. But as patent cliffs loom and the pressure to replenish drug pipelines intensifies, the time for change is now. Enter #DigitalHealth tools—the long-awaited game-changer. These cutting-edge innovations are not just reshaping biopharma research; they're catapulting traditional companies into the forefront of technological progress. The numbers speak volumes. #Partnerships between Biopharma and Digital Health ventures have skyrocketed 3.9 times from 2018 to 2023. What's particularly striking is the shift in focus within these collaborations. While #PatientSolutions and #MedicalDiagnostics held sway in 2018, #ResearchSolutions now command the spotlight, comprising 32% of partnerships in 2023. But amidst this wave of innovation, it's crucial to cut through the noise and discern the true trends shaping our industry's future. That's where Galen Growth | Insights You Can Trust's latest in-depth analysis comes in. Dive deep into biopharma's hottest innovation focus, separating fact from fiction and pinpointing the trailblazers and rising stars leading the charge. Are you ready to seize the opportunities presented by Digital Health? Join us at HealthTech Alpha—an unparalleled platform designed to equip you with the insights and tools needed to thrive in this dynamic landscape. Leverage cutting-edge data and propel your organisation ahead of the curve. Subscribe to HealthTech Alpha today and chart a course towards success in Digital Health! #Partnerships #DigitalHealth

Repurposing existing drugs isn’t just about cost savings - it’s about unlocking new possibilities that could improve the healthspan of humankind. Two FDA-approved drugs have already shown promising potential healthspan benefits. Our survey found that an overwhelming majority of medical experts are optimistic in this approach, seeing it as a viable approach to advancing the field. Yet, we know there are challenges - funding, competition, and the need for greater data transparency. Where does that leave us? It’s an opportunity. For biotech to innovate, invest, and lead the way in discovering new potential in what’s already on the market. So, beyond saving lives, what can existing drugs offer to #healthspan science? Are we ready to explore?

Curious about how technology is transforming #patientengagement in #clinicaltrials? Leen Kawas shares how new platforms can bridge the gap between patients, sponsors, and physicians. She also says what they did at her company. Hear her out. Find a link to the full conversation in a comment. #technology #biotech